This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Aspirin-Free Strategies in ACS: Is It the Drug or the Stent?
An editorial that may herald the decrease in aspirinization and the rise of ticagrelor monotherapy in Percutaneous stenting of coronary arteries. There might be a peripheral relevance to the group of our patients undergoing urgent surgical revascularisation after failed PCI: the balance of protecting the angioplasty versus minimising peri and postoperative heamorrhage is yet to be achieved.